Mutations of the noggin (NOG) and of the activin A type I receptor (ACVR1) genes in a series of twenty-seven French fibrodysplasia ossificans progressiva (FOP) patients

Genet Couns. 2009;20(1):53-62.

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare but very severe disease, characterised by congenital malformations of the toes and by progressive heterotopic ossification of muscles and joints. Two genes, the noggin (NOG) gene and the activin A type I receptor (ACVRI) gene, are involved in FOP. In this study we have searched for the NOG and the 617G>A (ACVR1) mutations in a well characterized series of twenty-seven French FOP patients. Five NOG mutations (delta 42, 274G>C, 275G>A, 276G>A, and 283G>A) have been found in seven (26%) of our FOP patients. The 617G>A mutation in the ACVR1 gene is found in fourteen (52%) of the patients. With one exception (patient number 22), 617G>A and NOG mutations are mutually exclusive in patients. Mutations 274G>C, 283G>A and 617G>A segregate with the trait in five different FOP families, some members of them being partially affected by the disease.

MeSH terms

  • Activin Receptors, Type I / genetics*
  • Adult
  • Age of Onset
  • Aged
  • Carrier Proteins / genetics*
  • Female
  • France / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Myositis Ossificans / epidemiology*
  • Myositis Ossificans / genetics*
  • Pedigree
  • Phenotype

Substances

  • Carrier Proteins
  • noggin protein
  • ACVR1 protein, human
  • Activin Receptors, Type I